Journal of the American Society of Nephrology (JASN) podcast

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

17/08/2022

Journal of the American Society of Nephrology (JASN)

0:00

8:54

Two highlighted clinical studies: the first addresses the effect of combining a SGLT2 inhibitor and a MRA on proteinuria; the second considers vascular reactivity as a risk factor for cerebral hypoxia when blood pressure falls during dialysis treatments.

D'autres épisodes de "Journal of the American Society of Nephrology (JASN)"

Daprodustat and Heart Failure in CKD
10/04/2024
19:18
Jonathan W. Cunningham and Ajay K. Singh discuss the results of their study, "Daprodustat and Heart Failure in CKD," with JASN Deputy Editor David H. Ellison.
Changes in ESKD Incidence
13/03/2024
10:41
Susan R. Mendley and Chyng-Wen Fwu discuss the findings of their study, "Age- and Race-Specific Changes in ESKD Incidence over Four Decades," with JASN Editor-in-Chief Rajnish Mehrotra.
Ne ratez aucun épisode de “Journal of the American Society of Nephrology (JASN)” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.
Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN
12/01/2024
25:36
In this podcast, outgoing Editor-in-Chief Josie Briggs talks with incoming Editor-in-Chief Raj Mehrotra about his vision for the next chapter of JASN.
SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade
21/11/2023
21:23
Dr. Briggs and Brendon Neuen discuss his paper in the December issue of JASN. This article on the CREDENCE and EMPA-CKD clinical trials shows that SGLT2 inhibitors allow more consistent use of RAS blockade in patients with declining renal function.
Kidney Transplant Registry Data: Advice for Users
24/10/2023
18:43
In this podcast, EIC Josie Briggs talks with Associate Editor John Gill about the valuable data resources for research on kidney transplantation. Drs. Gill and Briggs provide some advice for users of these important resources.
Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease
10/10/2023
25:37
In this podcast, EIC Josie Briggs talks with Giuseppe Remuzzi about the NEPHSTROM Trial & the next steps in translational work to test the possibility that mesenchymal stem cells can be used as a therapeutic agent to promote repair of kidney damage.
Historical Redlining and the Incidence of Kidney Failure in US Cities
24/08/2023
15:39
In the podcast, EIC Josie Briggs discusses a paper entitled "Structural Racism, Historical Redlining, and Incidence of Kidney Failure in US Cities" with co-authors Kevin Nguyen and Deidre Crews.
Antibiotic Use & Kidney Stones and Sodium Bicarbonate & the Vascular Dysfunction of CKD
24/07/2023
9:48
In the episode, EIC Josie Briggs discusses a randomized control trial addressing the impact of sodium bicarbonate on the vascular dysfunction in CKD and an observational case control study of the impact of antibiotic use on kidney stone formation.
How Many Nephrons in a Human Kidney? A New Number and a Discussion of Why it Matters
22/06/2023
15:12
In this podcast, Dr. Josie Briggs discusses with Dr. Andrew Rule his latest study showing the need to revise our estimate of the number of nephrons in the human kidney.
The Angiopoietin-Tie 2 Pathway is Ischemic Kidney Injury
23/05/2023
18:47
In this episode, JASN Associate Editor Katalin Susztak talks with Dr. Susan Quaggin about work from her laboratory on ischemic injury and translational targets in the Angiopoietin-Tie 2 pathway.

Plus d'épisodes

Découvrez le meilleur des podcasts sur l'application GetPodcast.

Abonnez-vous à tous vos podcasts préférés, écoutez les épisodes sans connexion internet et recevez des recommandations de podcasts passionnants.

Politique de confidentialité
Mentions légales
France

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

Journal of the American Society of Nephrology (JASN)

D'autres épisodes de "Journal of the American Society of Nephrology (JASN)"

Daprodustat and Heart Failure in CKD

Changes in ESKD Incidence

Dr. Briggs and Dr. Mehrotra discuss the next chapter for JASN

SGLT2 Inhibitors and Continuation of Renin Angiotensin Blockade

Kidney Transplant Registry Data: Advice for Users

Next Steps in Development of Mesenchymal Stem Cells as Possible Therapeutic for Kidney Disease

Historical Redlining and the Incidence of Kidney Failure in US Cities

Antibiotic Use & Kidney Stones and Sodium Bicarbonate & the Vascular Dysfunction of CKD

How Many Nephrons in a Human Kidney? A New Number and a Discussion of Why it Matters

The Angiopoietin-Tie 2 Pathway is Ischemic Kidney Injury